Illumina technology is pioneering genetic disease research, helping to advance breakthroughs in genetic health. With the significant impact of genetic disease and rare disease conditions on individuals of all ages and families worldwide, our focus is to develop solutions to facilitate early detection and intervention. This can help improve outcomes, promotes enduring good health, and raises awareness about the importance of one's genetic health. Our targeted gene panels, microarrays, and next-generation sequencing technologies can help genetic disease researchers identify causative genetic variants and chromosomal aberrations, and may enable early discovery.

To learn more, visit and follow @illumina.